You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 61 Issue 4

April 2006

Volume 61, Issue 4

Pages 365–486

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Monitoring for harms of therapy (pages 365–366)

      J. K. Aronson

      Version of Record online: 15 MAR 2006 | DOI: 10.1111/j.1365-2125.2006.02648.x

  2. Commentary

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Commentary : The phase 0 microdosing concept (pages 367–370)

      R. Colin Garner and Graham Lappin

      Version of Record online: 20 JAN 2006 | DOI: 10.1111/j.1365-2125.2006.02575.x

      • image
      • image
  3. Review

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Monitoring for adverse drug reactions (pages 371–378)

      J. J. Coleman, R. E. Ferner and S. J. W. Evans

      Version of Record online: 14 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02596.x

      • image
      • image
      • image
  4. Pharmacokinetics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort (pages 379–388)

      Sarah M. Robertson, Elizabeth Formentini, Raul M. Alfaro, Ven Natarajan, Judith Falloon and Scott R. Penzak

      Version of Record online: 14 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02593.x

      • image
      • image
  5. Pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Hyperalgesia induced by cutaneous freeze injury for testing analgesics in healthy volunteers (pages 389–397)

      Claude Chassaing, Jeannot Schmidt, Alain Eschalier, Jean Michel Cardot and Claude Dubray

      Version of Record online: 2 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02582.x

      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Plethysmography and impulse oscillometry assessment of tiotropium and ipratropium bromide; a randomized, double-blind, placebo-controlled, cross-over study in healthy subjects (pages 398–404)

      D. Singh, R. Tal-Singer, I. Faiferman, S. Lasenby, A. Henderson, D. Wessels, A. Goosen, N. Dallow, R. Vessey and M. Goldman

      Version of Record online: 14 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02594.x

      • image
      • image
      • image
      • image
  6. Pharmacokinetics & pharmacodynamics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
    2. You have free access to this content
      Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individuals (pages 414–419)

      Christiane Hesse, Steffen P. Luntz, Heike Siedler, Kristina Unnebrink, Gerd Mikus, Marianne de Bruijn, Edu Zondag, Michiel de Vries, Monika Seibert-Grafe and Walter E. Haefeli

      Version of Record online: 20 JAN 2006 | DOI: 10.1111/j.1365-2125.2006.02590.x

      • image
      • image
      • image
      • image
    3. You have free access to this content
      Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects (pages 420–426)

      Jagdev Sidhu, Sarah Job, Jonathan Bullman, Emma Francis, Richard Abbott, John Ascher and Jochen G. W. Theis

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1365-2125.2006.02598.x

      • image
      • image
  7. Drug interactions

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation (pages 427–439)

      Verawan Uchaipichat, Leanne K. Winner, Peter I. Mackenzie, David J. Elliot, J Andrew Williams and John O. Miners

      Version of Record online: 2 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02588.x

      • image
      • image
      • image
    2. You have free access to this content
      Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms (pages 440–450)

      Annika Bernsdorf, Thomas Giessmann, Christiane Modess, Danilo Wegner, Stefanie Igelbrink, Ute Hecker, Sierk Haenisch, Ingolf Cascorbi, Bernd Terhaag and Werner Siegmund

      Version of Record online: 20 JAN 2006 | DOI: 10.1111/j.1365-2125.2006.02599.x

      • image
      • image
      • image
      • image
      • image
  8. Therapeutics

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Efficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency (pages 451–455)

      Alberto M. Pereira, Agatha A. van der Klaauw, Hans P. F. Koppeschaar, Jan W. A. Smit, Sjoerd W. van Thiel, Jaap van Doorn, Nienke R. Biermasz, Ferdinand Roelfsema and Johannes A. Romijn

      Version of Record online: 2 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02585.x

      • image
      • image
  9. This Article has been Retracted

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
  10. Adverse drug reactions

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      QT interval prolongation associated with sibutramine treatment (pages 464–469)

      Mira Harrison-Woolrych, David W. J. Clark, Geraldine R. Hill, Mark I. Rees and Jonathan R. Skinner

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1365-2125.2006.02574.x

      • image
      • image
  11. Short report

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      A study of codispensing with sodium alendronate in Australia (pages 470–473)

      Ian W. Boyd, John McEwen and Lisa J. Calcino

      Version of Record online: 14 FEB 2006 | DOI: 10.1111/j.1365-2125.2006.02592.x

  12. Letter to the editors

    1. Top of page
    2. Editors' view
    3. Commentary
    4. Review
    5. Pharmacokinetics
    6. Pharmacodynamics
    7. Pharmacokinetics & pharmacodynamics
    8. Drug interactions
    9. Therapeutics
    10. This Article has been Retracted
    11. Adverse drug reactions
    12. Short report
    13. Letter to the editors
    1. You have free access to this content
      Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone (page 474)

      Benjamin Wyplosz, Sarah Vautier, Agnès Lillo-Le Louët and Loïc Capron

      Version of Record online: 24 JAN 2006 | DOI: 10.1111/j.1365-2125.2005.02576.x

    2. You have free access to this content

SEARCH

SEARCH BY CITATION